Series of blockbuster drugs to be expired in patent at the year end
At the end of this year, a series of large blockbuster drugs including an antidiabetic ‘Twynsta’ will be expired in patent, and a follow-up great war of generics is about to occur.
According to the pharmaceutical industry, starting with ‘Twynsta’ on the 18th August, PMSs and patents of large blo...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
